Immune system study for diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the immune system works in people with diabetic kidney disease. It tests whether certain blood pressure medicines can help protect the kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is below 30
- You have not had any major blood vessel problems (like heart attack, stroke, or leg artery disease)
- You are taking a high dose of an ACE inhibitor or ARB medicine for blood pressure
- You do not have a BMI of 30 or above
- You have no known blockages in your large arteries
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the bacteria in your gut and certain substances in your blood might affect blood sugar changes and kidney health in people with diabetic kidney disease. If you have type 2 diabetes and kidney issues, this trial could help find better ways to track your condition.
This study looks at certain blood markers (immune system and platelets) in people with diabetic kidney disease compared to healthy people. It may help doctors better understand and manage diabetes-related kidney damage.
This study looks at how people with diabetic kidney disease participate in their own care. It aims to understand what helps or hinders engagement, which could lead to better support for patients.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This study tests a new care approach for people with diabetes who have early-to-moderate kidney disease. The goal is to help prevent serious kidney and heart problems by improving how care is coordinated.
This trial is developing and checking a new technique to detect early diabetic nephropathy, which means early damage to the kidneys caused by diabetes. It may help people catch kidney problems sooner, so treatment can start earlier.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.